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Abstract
Estrogens play a significant role in breast cancer development and are not only produced
endogenously, but are also mimicked by estrogen-like compounds from environmental
exposures. We evaluated associations between estrogenic (E) activity, demographic factors
and breast cancer risk factors in Non-Latina Black (NLB), Non-Latina White (NLW), and
Latina women. We examined the association between E activity and Indigenous American
(IA) ancestry in Latina women. Total E activity was measured with a bioassay in plasma
samples of 503 women who served as controls in the San Francisco Bay Area Breast Can-
cer Study. In the univariate model that included all women with race/ethnicity as the inde-
pendent predictor, Latinas had 13% lower E activity (p = 0.239) and NLBs had 35% higher
activity (p = 0.04) compared to NLWs. In the multivariable model that adjusted for demo-
graphic factors, Latinas continued to show lower E activity levels (26%, p = 0.026), but the
difference between NLBs and NLWs was no longer statistically significant (p = 0.431). An
inverse association was observed between E activity and IA ancestry among Latina women
(50% lower in 0% vs. 100% European ancestry, p = 0.027) consistent with our previously
reported association between IA ancestry and breast cancer risk. These findings suggest
that endogenous estrogens and exogenous estrogen-like compounds that act on the estro-
gen receptor and modulate E activity may partially explain racial/ethnic differences in breast
cancer risk.
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Introduction
Epidemiological studies have consistently reported that endogenous sex hormones play a critical
role in the etiology of numerous diseases including breast cancer [1–4]. Interestingly, among U.S.
racial/ethnic groups the reported variation in endogenous hormone levels is consistent with
observed racial/ethnic differences in the incidence of breast cancer [5–7]. For example, in the
Women’s Health Initiative Dietary Modification Trial, African American women had signifi-
cantly higher concentrations of endogenous reproductive hormones compared to non-Latina
White women [8], whereas higher levels of urinary concentrations of estrogens were strongly
associated with breast cancer risk in Asian women in the Shanghai Women’s Study cohort [9].
Moreover, in the Multiethnic Cohort study, postmenopausal Native Hawaiian and African Amer-
ican women tended to have higher levels of endogenous hormones when compared to non-Latina
Whites (NLWs) [10], while foreign-born Hispanic/Latina women (referred to as Latinas hereaf-
ter) had lower hormone levels which correlates with their lower incidence of breast cancer [5].
Changes in lifestyle and demographic factors can influence endogenous estrogen levels
through changes in adiposity. Across racial/ethnic groups, multiple studies have consistently
identified a positive association between body mass index (BMI) and estrogen levels [11], [12].
In Latina women, adaptation of a Western lifestyle, along with greater physical inactivity have
served as potential explanations for changes in BMI [13]. Estrogen plays a significant role in
breast cancer and is not only produced endogenously, but is also mimicked by exogenous
sources including xenoestrogens and phytoestrogens [14–16] like bisphenol A (BPA), diethyl-
stilbestrol (DES), atrazine, and soy products. It is because of this dual role that endogenous
and exogenous sources could contribute to differences in breast cancer incidence rates in dif-
ferent racial/ethnic populations across the U.S. [17].
Various methods are available to quantify estrogen receptor (ER) function and activation.
Luciferase assays have been widely used and have proven useful in predicting breast cancer risk
[18], [19]. Generally, due to the fluctuations of estrogens throughout the menstrual cycle, estro-
gen measures have been more consistent for postmenopausal than premenopausal women [20].
In a previous pilot study among foreign-born and U.S.-born Mexican women who partici-
pated as controls in a population-based case-control study of breast cancer, we found that plasma
estrogenic (E) activity was associated with genetic ancestry and years of U.S. residence [18], sug-
gesting the possibility of a hormone related pathway for the observed racial/ethnic differences in
breast cancer risk. In the present study, we examined total E activity accounting for both endoge-
nous and exogenous sources of estrogenic compounds in plasma of 503 women, the majority of
them postmenopausal, from three racial/ethnic groups. We hypothesize that differences in breast
cancer risk in different racial/ethnic groups could be partly due to variations in endogenous
estrogens and exogenous estrogen-like exposures. We evaluated the association between E activ-
ity, demographic and lifestyle factors in non-Latina Black (NLB), NLW, and Latina women,
accounting for endogenous estrogen levels. We also used a larger sample of Latina women to val-
idate the previously observed association between E activity and Indigenous American (IA)
ancestry [18]. The approach we used provides an efficient way to assess endogenous and exoge-
nous exposures and provides insights on a mechanistic connection that explains the differences
in breast cancer incidence rates in different racial/ethnic populations living in the US.
Materials and methods
Study samples/ control selection
Participants were selected from the control group of the San Francisco Bay Area Breast Cancer
Study (SFBCS), a population-based case-control study in Latina, NLB, and NLW women [13].
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Controls living in San Francisco, San Mateo, Alameda, Contra Costa or Santa Clara counties
were identified through random-digit dialing and frequency matched to breast cancer cases diag-
nosed from 1995–2002 in the same counties on race/ethnicity and 5-year age group. Blood sam-
ples were collected for a subset of study participants (cases diagnosed from 1997–2002 and their
matched controls). Professional trained interviewers administered a questionnaire on breast can-
cer risk factors in English or Spanish at a home visit and took anthropometric measurements.
Blood samples were collected shortly after the interview and in some instances a few years after
the interview as part of an ancillary study. A short questionnaire was administered at time of
blood draw to obtain updates on key variables (current menstrual status and weight; pregnancy,
breast-feeding, smoking, alcohol consumption, and medication use in the previous 6 months).
In the present study, we measured E activity in plasma samples of 503 women (329 Latinas,
100 NLBs, and 74 NLWs) from the control group of SFBCS. Eight percent of the participants
were premenopausal and equally distributed among the different racial/ethnic groups. To pre-
vent exposure misclassification of exogenous estrogen use, we excluded women who were
using hormone therapy at the time of blood draw. Participants who had one or more missing
covariates were excluded from the analyses (11 women in analyses without adjustment for
endogenous estrogens; 15 women in analyses with adjustment for endogenous estrogens).
All study participants provided written informed consent. The study was approved by the
Institutional Review Boards at the University of California, San Francisco and the Cancer Pre-
vention Institute of California.
Endogenous hormone measurements
Plasma hormone measurements were performed at the Reproductive Endocrine Research lab-
oratory at the University of Southern California under the direction of one of the contributing
authors (FZS). Methods are described elsewhere [5]. Briefly, plasma concentrations of estrone
and bioavailable estradiol were obtained by a radioimmunoassay method after organic solvent
extraction and Celite column partition chromatography. Reported endogenous estrogen levels
are the sum of estrone and bioavailable estradiol in free and albumin bound form. The assay
sensitivities for estrone and estradiol are 4 pg/ml and 2 pg/ml, respectively, and the inter-assay
coefficient of variation (CV) for each assay is less than 12%.
Estrogenic activity measurement
We utilized a receptor-mediated Chemical-Activated Luciferase gene eXpression (CALUX) assay
for the assessment of total E activity profiles in human plasma, which captures levels of both
endogenous and exogenous estrogenic compounds. Methods followed procedures as previously
described [18], [21]. Briefly, endogenous and exogenous estrogens and estrogen-like compounds
(e.g., 17-beta estradiol (E2), phytoestrogens, 4-nonylphenol) in human plasma were measured
using a transfected human breast cancer cell line with luciferase reporter, T47D-Kbluc (ATCC,
Manassas, VA). Cells were cultured in phenol red DMEM with 10% FBS until one week prior to
cell treatment with plasma. Cells were placed in phenol red free DMEM media with 10% charcoal
dextran serum to ensure removal of all external sources of estrogens for one week prior to plasma
addition. After one week in phenol red free medium, cells between passage 10 and 16 were seeded
at a density of 27,000 cells per well and a final volume of 200 uL per well in 96-well microtiter
plates and incubated at 37 degrees Celsius. After a 24 hour incubation period, 8uL of plasma per
sample was diluted in phenol red free medium and added in quadruplicates directly onto the
cells. A second incubation period of 24 hours at 37 degrees Celsius followed plasma addition.
Lastly, cells were lysed using 1X passive lysis buffer (Promega, Madison, WI, USA) and results
were obtained using a microplate luminometer (Berthold Technologies, Oak Ridge, TN, USA).
Estrogenic activity in San Francisco Bay Area women
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Reporter activity was measured by the fluorescence emitted per well. Results were expressed in
relative light units (RLUs) with higher RLU values reflecting greater E activity in plasma. Four
RLU readings per sample were averaged to express results as one measure. The measurement was
converted to picomolar (pM) equivalents based on the standard curve of (17β)-estra-1,3,5(10)-tri-
ene-3,17-diol, or 17β-estradiol (Tocris Bioscience, Bristol, UK) on each plate expanding a range
of 0.0 pM to 25.0 pM. Samples from each racial/ethnic group were included within each batch.
Lab personnel were blinded to the race/ethnicity of the samples. The minimum limit of detection
for estradiol is 1.0 pM and the intra-assay (technical) and inter-assay (biological) CVs of this assay
are between 7–23%, with higher values often corresponding to premenopausal women.
Statistical methods
All hormone values were natural log (ln) transformed to approximate normal distribution.
Differences in means or proportions for all analyzed variables between racial/ethnic groups
were assessed using two-sided t-tests and Fisher’s exact tests, respectively. Linear regression
was used to analyze the relationship between ln-transformed and plate adjusted E activity
(dependent variable) and race/ethnicity (main predictor). Plate adjusted values were obtained
by first estimating average plate effects using linear regression and then subtracting the average
plate effect from each individual value. Percent change in RLUs per unit change of predictor
variables was calculated using the formula [eβ-1]�100. Statistical significance was set at p<0.05.
All statistical analyses were performed using the program Stata [22].
The present study assessed differences in E activity by race/ethnicity and tested associations
between E activity and various factors that were hypothesized to affect E activity levels (i.e.,
height, BMI, age, alcohol intake, and neighborhood SES). Multivariable regression models
included several independent variables such as race/ethnicity (Latina, NLW, NLB), age at
blood draw (categorical, <55, 55 to 65 and� 66 years), height (continuous, in centimeters),
body mass index (BMI) at blood draw (categorical, <25, 25–29.9, and�30 kg/m2), neighbor-
hood socioeconomic status (SES) (categorical, 1 = low SES, 5 = high SES) geocoded to a Cen-
sus 2000 block group, alcohol intake during the calendar year before selection into the parent
study (categorical, grams per day), and E activity (continuous, log-transformed). Selection of
these variables was based on factors we previously hypothesized could affect E activity at time
of blood draw [18]. BMI was calculated as self-reported weight (kg) at blood draw / height
squared (m) measured at interview. For a subset of Latina women (n = 276), information was
available on IA ancestry. Proportion of IA ancestry was used as a continuous variable with val-
ues ranging from 0 to 100%. The multivariable model for the ancestry analysis included IA
ancestry, age at blood draw, height, BMI, neighborhood SES, alcohol intake, and nativity (for-
eign-born vs. U.S.-born). Analyses were also adjusted for endogenous estrogen measurements.
Data on reproductive variables were available from the interview (i.e., age at menarche, age
at first full term pregnancy, number of full term pregnancies). We ran multivariable models
adjusting for reproductive variables, but as we had previously hypothesized, they did not have
an effect on E activity at blood draw, which for most women occurred many years after the
individual’s last pregnancy. Therefore, final models do not adjust for reproductive variables.
Additionally, because the average age at blood draw for all three racial/ethnic groups was over
the age of 60 years, which is about 10 years after the average age of menopause in U.S. women,
final models did not adjust for age at menopause.
Results
Descriptive characteristics by racial/ethnic groups are presented in Table 1. After adjusting for
plate, ER RLUs were highest for NLB women (mean of 8844 RLUs), followed by NLWs (mean
Estrogenic activity in San Francisco Bay Area women
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Table 1. Participant characteristics by racial/ethnic group (N = 503).
Continuous variables Latinas NLWs NLBs P value
N Mean Sd. N Mean Sd. N Mean Sd.
Estrogenic Activity in RLUs
Median (IQR)
329 6226
2452 (1582–
4478)
12899 74 8155
2248 (1722–
4691)
13307 100 8844
3335 (1883–
10124)
11260 0.0157
Endogenous estrogen levela, pg/mL
Median (IQR)
327 58.9
46.7 (34.5–64.5)
49.4 74 52.1
40.9 (34.5–60.4)
32.1 100 64.0
53.6 (36.5–81.3)
38.2 0.0613
Age at blood draw (years) 329 61.5 9.5 74 66.8 10.5 100 61.7 9.8 0.0001
Age at menarche, yrs 326 12.9 1.9 74 12.8 1.5 99 12.7 1.7 0.6396
Age at first full term pregnancy, yrs 306 23.0 5.2 58 24.2 4.8 88 20.8 4.9 0.0001
Number of full term pregnancies 329 3.8 2.7 74 2.4 1.8 100 2.8 2.2 <0.0001
Height (cm) 324 155.5 6.9 73 161.1 7.3 100 163.3 6.2 <0.0001
Individual African Ancestry proportion (%) 285 8 7
Individual Indigenous American ancestry proportion
(%)
285 41 15
Categorical variables Latinas NLWs NLBs P value
N % N % N %
Nativity
U.S.-born 112 34 68 92 97 97 <0.0001
Foreign-born 217 66 6 8 3 3
Family history of breast cancerb
No 290 88 62 84 88 88 0.559
Yes 39 12 12 16 12 12
Alcohol intake (gms per day)c
None 235 71 34 46 76 76 <0.0001
<10 82 25 20 27 15 15
�10 12 4 20 27 9 9
BMI (kg/m2)
<25 42 13 22 30 16 16 <0.0001
25–29.9 122 38 30 41 24 24
�30 160 49 21 29 60 60
Age at blood draw (years)
<55 94 29 14 19 31 31 0.001
55–65 117 36 13 18 31 31
�66 118 36 47 64 38 38
Menopausal status at blood draw
Premenopausal 28 9 8 11 6 7 0.571
Postmenopausal 274 91 63 89 86 93
History of oophorectomy and/or hysterectomy 46 14 10 14 27 27 0.010
Neighborhood socioeconomic status (SES)
1 (low SES) 17 5 3 4 23 23 <0.0001
2 77 24 6 8 30 30
3 91 28 12 16 25 25
4 80 25 21 29 11 11
5 (high SES) 61 19 31 42 10 10
NLW, Non Latina White; NLB, Non Latina Black; RLUs, relative light units reported by bioassays (untransformed)
a Sum of endogenous estrogens including estrone and bioavailable estradiol (free and albumin bound)
b First degree relatives
c Alcohol intake during calendar year before selection into parent study
https://doi.org/10.1371/journal.pone.0213809.t001
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of 8155 RLUs), and lowest for Latina women (mean RLUs of 6226). NLW women were older
at blood draw (66.8 yrs, sd. 10.5 yrs) when compared to NLB (61.7 yrs, sd. 9.8 yrs) and Latina
(61.5 yrs, sd. 9.5 yrs) women. Age at menarche was similar for the three groups. NLB women
had the lowest age at first full term pregnancy (21 yrs, sd. 5 yrs). However, Latina women had
a greater number of full term pregnancies (3.8) compared to the NLW (2.4) and NLB women
(2.8). Latina women were on average shorter than NLBs and NLWs. A large percentage (66%)
of the Latina women in this study were foreign-born, while over 90% of the NLW and NLB
women were U.S.-born. About 87% and 84% of the Latina and NLB women, respectively, were
categorized as overweight or obese. A greater proportion of NLW women reported consuming
some alcohol (54%), while 76% and 71% of NLB and Latina women, respectively, reported no
alcohol intake during the year before the interview. Lastly, women in this study were predomi-
nantly postmenopausal either naturally or due to surgery. Although a statistically significant
greater proportion (27%) of NLB women had a history of hysterectomy and/or oophorectomy
compared to NLW and Latina women, menopausal status did not differ between the three
racial/ethnic groups.
In the univariate model (Table 2), Latinas had 13% lower E activity (p = 0.239) and NLBs
had 35% higher activity (p = 0.04) compared to NLWs. After adjusting for endogenous estro-
gens, the trend was consistent with 11% higher E activity in NLB women and 21% lower activ-
ity in Latina women; however, the association was statistically significant only for Latina
women (p = 0.019). In the multivariable model, Latinas showed lower E activity before (26%,
p = 0.026) and after (25%, p = 0.01) adjusting for endogenous estrogens. Although E activity in
NLBs continued to remain higher than that of NLWs, the difference between the two groups
was no longer statistically significant before (13%, p = 0.431) or after (5%, p = 0.673) adjust-
ment for endogenous estrogens. We observed a decrease in E activity with increasing age,
which was no longer statistically significant after adjustment for endogenous estrogens. In
unadjusted models, E activity was 67% higher for obese women (p<0.001) and 40% higher for
overweight women (p = 0.006) when compared to those with normal BMI (p<0.001), but
these associations were no longer apparent after adjusting for endogenous estrogen levels.
Overall, no statistically significant associations were observed with neighborhood SES before
or after adjustment for endogenous estrogens. Compared to women who reported no alcohol
consumption, those who consumed <10gms of alcohol had lower E activity before (21%,
p = 0.017) and after (17%, p = 0.024) adjusting for endogenous estrogens.
Restricting the analysis to Latina women with information on genetic ancestry (N = 276),
we found that in the univariate model higher IA ancestry was associated with lower E activity
(Table 3). This finding was statistically significant prior to adjusting for endogenous estrogens
(52%, p = 0.031) and marginally significant after adjustment (39%, p = 0.088). In the multivari-
able analysis, increasing age was associated with lower E activity. As with the full sample, the
significant associations with BMI were no longer statistically significant after adjusting for
endogenous estrogens. No statically significant associations were observed for height, neigh-
borhood SES or nativity.
Discussion
Our study shows that there are significant differences in E activity in women across three
racial/ethnic groups, partly due to differences in BMI (in the case of NLWs vs. NLBs) and
potential exposure to exogenous estrogen-like compounds (NLWs vs. Latinas). Results also
suggest that higher IA ancestry in Latina women is associated with lower levels of E activity,
which is consistent with the observation that Latina women with high IA ancestry have lower
risk of developing breast cancer.
Estrogenic activity in San Francisco Bay Area women
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There was an association between BMI and E activity in all racial/ethnic groups. In NLB
women, higher E activity was mostly attributed to BMI. After inclusion of the BMI variable in
the multivariable model, the level of E activity among NLBs was no longer statistically different
from NLWs. The attenuation of the positive association between E activity and BMI after
adjusting for endogenous estrogen levels in the regression model is consistent with previous
observations [23–25]. In overweight and obese postmenopausal women, the adipose tissue
serves as the primary source of estrogen synthesis and leads to elevated estrogen measures.
This is likely to be one of multiple mechanisms underlying the association between BMI and
breast cancer risk in postmenopausal women [11]. Interestingly, weight loss interventions [26]
in postmenopausal women have been associated with lower circulating estradiol, suggesting a
Table 2. Association of estrogenic activity with lifestyle and demographic factors in all women (N = 488) using univariate and multivariable analyses.
Univariate Coefficienta
(95% CI)
%Change in RLUs� P value Adjusted by endogenous estrogensb %Change in RLUs� P value
Race/ethnicity#
NLW ref ref
NLB 0.30 (0.01, 0.58) 35 0.04 0.10 (-0.13, 0.32) 11 0.398
Latina -0.14 (-0.38, 0.10) -13 0.239 -0.23 (-0.42, -0.04) -21 0.019
Multivariable
Race/ethnicity
NLW ref ref
NLB 0.12 (-0.18, 0.43) 13 0.431 0.05 (-0.20, 0.31) 5 0.673
Latina -0.30 (-0.57, -0.04) -26 0.026 -0.29 (-0.50, -0.07) -25 0.01
Age at blood draw (years)
<55 ref ref
55–65 -0.32 (-0.53, -0.11) -27 0.003 -0.01 (-0.19, 0.16) -1 0.884
>65 -0.41 (-0.62, -0.21) -34 <0.001 -0.06 (-0.24, 0.11) -6 0.491
Height, cm 0.01 (-0.01, 0.02) 1 0.33 0.00 (-0.01, 0.01) 0 0.684
BMI (kg/m2)
<25 ref ref
25–29.9 0.34 (0.10, 0.59) 40 0.006 0.12 (-0.10, 0.32) 13 0.272
�30 0.51 (0.27, 0.75) 67 <0.001 0.13 (0.08, 0.33) 14 0.225
Neighborhood SES
1 (low) ref ref
2 0.27 (-0.06, 0.60) 31 0.114 0.12 (-0.15, 0.39) 13 0.39
3 0.10 (-0.23, 0.43) 11 0.565 0.01 (-0.26, 0.28) 1 0.915
4 0.31 (-0.03, 0.65) 36 0.078 0.20 (-0.08, 0.48) 22 0.163
5 (high) 0.25 (-0.10, 0.60) 28 0.157 0.10 (-0.18, 0.39) 11 0.475
Alcohol intake (gms/day)c
None ref ref
<10 -0.24 (-0.44, -0.04) -21 0.017 -0.19 (-0.35, -0.02) -17 0.024
�10 -0.25 (-0.57, 0.07) -22 0.122 -0.20 (-0.46, 0.06) -18 0.129
CI, confidence interval
# ANOVA p-value = 0.002
� Luciferase reporter assay results expressed in relative light units (RLUs). Percent change in RLUs (untransformed) per unit change in predictor was estimated using
the formula [e β − 1] � 100.
a The coefficients and 95% CI are based on the ln-transformed RLUs
b Sum of endogenous estrogens including estrone and bioavailable estradiol (free and albumin bound)
c Alcohol intake during calendar year before selection into parent study
https://doi.org/10.1371/journal.pone.0213809.t002
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reversal of peripheral production of estrogens via reduction of adipose tissue. Since the associ-
ation between E activity and BMI is present in all racial/ethnic groups, a reduction of E activity
through weight management could lead to breast cancer risk reduction in all women. The
lower E activity among Latinas, especially among Latina women with high IA ancestry, was
not fully explained by the relationship between BMI and endogenous estrogen levels and
should be further investigated.
Another lifestyle factor that showed association with E activity was alcohol intake. Alcohol
intake is associated with risk of several cancers including breast cancer. However, studies look-
ing at the effects of alcohol consumption on circulating levels of endogenous estrogen have
produced inconsistent results. Some studies reported that increased alcohol consumption is
associated with higher circulating estrogens [27], while others found no association [28]. Our
results are not consistent with previous findings, given that our data show an inverse associa-
tion between E activity and alcohol consumption. More studies that include samples from
Table 3. Association between estrogenic activity and Indigenous American ancestry in Latina women (N = 276) using univariate and multivariable
analysesUnivariate.
Univariate Coefficient
(95% CI) a
%Change in RLUs� P value Coefficient
(95% CI) a
%Change in RLUs� P value
Indigenous American ancestry -0.74 (-1.41, -0.07) -52 0.031 -0.49 (-0.06, 0.07) -39 0.088
Multivariable Model Ab Model A + endogenous estrogens
Indigenous American ancestry -1.10 (-1.84, -0.35) -67 0.004 -0.71 (-1.34, -0.081) -51 0.027
Age at blood draw (years)
<55 ref ref
55–65 -0.28 (-0.55, -0.01) -24 0.041 -0.01 (-0.24, 0.22) -1 0.918
>65 -0.37 (-0.64, -0.10) -31 0.008 -0.05 (-0.28, 0.19) -5 0.681
Height, cm -0.00 (-0.02, 0.01) 0 0.58 -0.01 (-0.02, 0.01) -1 0.431
BMI (kg/m2)
<25 ref ref
25–29.9 0.49 (0.15, 0.84) 63 0.005 0.25 (-0.05, 0.54) 28 0.107
�30 0.47 (0.13, 0.82) 60 0.006 0.17 (-0.12, 0.47) 19 0.251
Neighborhood SES
1 (low) ref ref
2 0.17 (-0.32, 0.67) 19 0.491 0.01 (-0.41, 0.43) 1 0.956
3 -0.02 (-0.50, 0.47) -2 0.948 -0.03 (-0.44, 0.38) -3 0.887
4 0.23 (-0.27, 0.73) 26 0.364 0.12 (-0.30,0.54) 13 0.589
5 (high) 0.18 (-0.33, 0.70) 20 0.49 0.09 (-0.35, 0.52) 9 0.697
Alcohol intake (gms/day)c
None ref
<10 -0.35 (-0.59, -0.10) -30 0.007 -0.24 (-0.45, -0.03) -21 0.026
�10 -0.16 (-0.69, 0.38) -15 0.561 -0.15 (-0.60, 0.30) -14 0.511
Foreign born
Yes -0.02 (-0.26, 0.22) -2 0.899 -0.03 (-0.23, 0.17) -3 0.779
CI, confidence interval
� Luciferase reporter assay results expressed in relative light units (RLUs). Percent change in RLUs (untransformed) per unit change in predictor was estimated using
the formula [e β − 1] � 100.
a The coefficients and 95% CI are based on the ln-transformed RLUs
b Unadjusted for endogenous estrogen levels
c Alcohol intake during calendar year before selection into parent study
https://doi.org/10.1371/journal.pone.0213809.t003
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diverse populations are needed to identify the effects of alcohol consumption on endogenous
estrogen levels.
The association between IA ancestry and E activity among Latinas even after adjusting for
endogenous estrogens suggests that in this group, the E activity could be related to environ-
mental exposures such as exogenous chemicals or dietary constituents. Soy-based and vegeta-
ble-derived foods containing several phytoestrogens are common in the diet of Latino
populations [29]. Because phytoestrogens have a similar chemical structure to estradiol, they
may compete with estrogens for binding to ER. Dietary lignan consumption has been found to
be associated with reduced risk of postmenopausal breast cancer specifically in ER and proges-
terone receptor-positive cases, suggesting that these compounds are acting through an ER
related mechanism [30]. However, this hypothesis needs to be further investigated. Another
explanation for the lower E activity among Latina women with high IA ancestry after adjusting
for endogenous estrogen levels would be a biological difference in the metabolism of estrogen
and estrogen-like compounds, resulting in a fewer number of molecules that could adequately
bind to the ER [31]. Some studies have demonstrated that estrogen metabolism and hydroxyl-
ation of parent estrogen compounds at different positions around the steroid ring, mainly
2-hydroxylation, is associated with reduced risk of postmenopausal breast cancer [32].
An important strength of the present study is the diverse study population and the larger
sample set of Latina women included in the analysis of IA ancestry (n = 276) compared to our
previous pilot study that included only 90 Mexican women [18]. Using this larger sample size,
we have validated our previous findings of a negative association between E activity and IA
ancestry. The association between endogenous estrogen levels and IA ancestry was statistically
significant and could partly explain why Latina women with higher IA ancestry have a lower
incidence of breast cancer. Furthermore, we were able to assess E activity using a commonly
used bioassay and correlate measures with endogenous estrogen levels. The Pearson correla-
tion coefficient between the two methods was high (0.62, p<0.0001). Although the methods
were not perfectly correlated, our results highlight the potential role of exogenous estrogenic
compounds in the activation of the ER and the concomitant effects on the endocrine system.
More importantly, given that most breast cancer grows in the presence of estrogens, under-
standing what factors (of endogenous and exogenous origin) might stimulate or block the
estrogen receptor among women of different racial/ethnic backgrounds is of great relevance.
Our study also has some limitations. Although we were able to assess total E activity in
plasma samples and account for endogenous estrogens, this approach does not allow us to
determine the specific estrogen-like compounds that are acting on the ER. However, we report
total E activity, which encompasses both endogenous and exogenous estrogens and is a com-
prehensive representation of estrogenic exposure. Additionally, our results are based on blood
samples from a single time point, which may not represent the fluctuations of estrogens over
time. Yet, the endogenous estrogen levels in postmenopausal women are relatively stable over
time [33] and fluctuations in total estrogens will be mostly due to exogenous estrogens that are
captured by the bioassay. Our study only included control women; assessing associations with
breast cancer risk using a case-control design is not feasible because measuring E activity in
plasma from breast cancer cases would not reflect E activity before diagnosis. However, the
association between levels of circulating estrogens and breast cancer risk is well established
[31], highlighting the significance of the associations reported in the present study for breast
cancer risk. Further replication of the association between race/ethnicity, BMI, genetic ances-
try, E activity, endogenous hormones and breast cancer risk in a prospective cohort with infor-
mation about possible sources of exogenous estrogens (i.e., diet) and genetic data will provide
the ideal setting to investigate the role that estrogen-related factors play in explaining differ-
ences in breast cancer incidence between racial/ethnic groups. Such knowledge could lead to
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race/ethnicity/ancestry-specific interventions focused on lowering E activity to reduce the risk
of developing breast cancer in all racial/ethnic groups.
Conclusions
Given the central role of the activation of the ER in the etiology of breast cancer, a better
understanding of the receptor’s interaction with the receptor ligands, whether endogenous or
exogenous, is imperative. Additionally, the discovery of specific compounds that are modulat-
ing the receptor and are present at different levels in different populations, would lead to
changes in exposure to these compounds and ultimately, to changes in breast cancer risk.
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